Rocket Pharmaceuticals In... (RCKT)
NASDAQ: RCKT
· Real-Time Price · USD
6.63
-0.37 (-5.29%)
At close: May 13, 2025, 3:59 PM
6.56
-0.98%
Pre-market: May 14, 2025, 09:28 AM EDT
-5.29% (1D)
| Bid | 6.51 |
| Market Cap | 713.76M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -258.75M |
| EPS (ttm) | -2.73 |
| PE Ratio (ttm) | -2.43 |
| Forward PE | -4.37 |
| Analyst | Buy |
| Ask | 6.7 |
| Volume | 4,020,597 |
| Avg. Volume (20D) | 2,930,086.1 |
| Open | 7.00 |
| Previous Close | 7.00 |
| Day's Range | 6.24 - 7.13 |
| 52-Week Range | 4.55 - 26.98 |
| Beta | 1.02 |
About RCKT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RCKT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RCKT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Rocket Pharmaceuticals has released their quartely earnings
on May 8, 2025:
5 months ago
-2.38%
Rocket Pharmaceuticals shares are trading lower af...
Unlock content with
Pro Subscription
6 months ago
+8.27%
Rocket Pharmaceuticals shares are trading higher after Scotiabank initiated coverage on the stock with a Sector Outperform rating on the stock and announced a $50 price target.
